Published in Immunobiology on December 24, 2009
Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition. Biochim Biophys Acta (2012) 0.93
Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm Res (2012) 0.86
The involvement of microglial cells in Japanese encephalitis infections. Clin Dev Immunol (2012) 0.85
Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity. PLoS One (2011) 0.85
Antiviral macrophage responses in flavivirus encephalitis. Indian J Med Res (2013) 0.78
Recent advances in Japanese encephalitis. F1000Res (2017) 0.75
Regulation of inflammation in Japanese encephalitis. J Neuroinflammation (2017) 0.75
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ (2007) 5.61
Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ (2005) 4.52
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med (2008) 4.33
Projecting the future diabetes population size and related costs for the U.S. Diabetes Care (2009) 3.34
Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes (2005) 2.28
Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia (2007) 2.04
Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis (2009) 1.82
Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem (2008) 1.65
Using clinical information to project federal health care spending. Health Aff (Millwood) (2009) 1.62
Multilevel modeling and practice-based research. Ann Fam Med (2005) 1.58
Relationship between quality of care of hospitalized vulnerable elders and postdischarge mortality. J Am Geriatr Soc (2010) 1.56
Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study. J Gen Intern Med (2006) 1.55
Inflammation: a new candidate in modulating adult neurogenesis. J Neurosci Res (2008) 1.55
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care (2008) 1.48
Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide--a potential antileishmanial agent. Bioorg Med Chem (2002) 1.44
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care (2010) 1.43
Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res (2010) 1.28
A CTSA agenda to advance methods for comparative effectiveness research. Clin Transl Sci (2011) 1.21
Protective and vulnerability factors predicting new-onset depressive episode in a representative of U.S. adolescents. J Adolesc Health (2008) 1.18
Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. J Neuroinflammation (2010) 1.15
Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories. Med Decis Making (2007) 1.14
Risk stratification for sudden cardiac death: a plan for the future. Circulation (2014) 1.14
Minimal modeling approaches to value of information analysis for health research. Med Decis Making (2011) 1.12
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother (2007) 1.11
Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke (2005) 1.10
The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research. Pharmacoeconomics (2010) 1.09
RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection. PLoS One (2011) 1.07
Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull (2007) 1.05
Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett (2007) 1.05
STING mediates neuronal innate immune response following Japanese encephalitis virus infection. Sci Rep (2012) 1.05
Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther (2007) 1.05
Tobacco carcinogen induces microglial activation and subsequent neuronal damage. J Neurochem (2009) 1.04
Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells. J Neurochem (2010) 1.03
Does competition under Medicare Prospective Payment selectively reduce expenditures on high-cost patients? Rand J Econ (2002) 1.02
The complexity of medication regimens and test ordering for patients with diabetes from 1995 to 2003. Curr Med Res Opin (2007) 1.01
Japanese encephalitis virus induce immuno-competency in neural stem/progenitor cells. PLoS One (2009) 1.01
NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS One (2012) 1.01
Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent. Neurochem Int (2009) 1.00
Japanese Encephalitis Virus infection induces IL-18 and IL-1beta in microglia and astrocytes: correlation with in vitro cytokine responsiveness of glial cells and subsequent neuronal death. J Neuroimmunol (2008) 0.99
Tumor necrosis factor receptor-1-induced neuronal death by TRADD contributes to the pathogenesis of Japanese encephalitis. J Neurochem (2007) 0.98
Comparative effectiveness research for antipsychotic medications: how much is enough? Health Aff (Millwood) (2009) 0.97
Japanese encephalitis virus infection decrease endogenous IL-10 production: correlation with microglial activation and neuronal death. Neurosci Lett (2007) 0.97
Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J Neurochem (2008) 0.96
MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1. J Virol (2014) 0.96
A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation. PLoS One (2010) 0.96
Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury. J Neuroinflammation (2006) 0.95
Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis. PLoS Negl Trop Dis (2010) 0.95
Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One (2011) 0.94
Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. J Neuroimmune Pharmacol (2009) 0.94
Antioxidant potential of Minocycline in Japanese Encephalitis Virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem Int (2009) 0.94
Viral infection and neural stem/progenitor cell's fate: implications in brain development and neurological disorders. Neurochem Int (2011) 0.93
Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis. J Neuroimmune Pharmacol (2010) 0.93
MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. J Neurochem (2013) 0.92
Use of minocycline in viral infections. Indian J Med Res (2011) 0.92
Neurons under viral attack: victims or warriors? Neurochem Int (2010) 0.91
Regulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells. J Neuroinflammation (2014) 0.90
Epigenetic modulation of host: new insights into immune evasion by viruses. J Biosci (2010) 0.90
Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan. J Antimicrob Chemother (2008) 0.89
Tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis. Neurochem Int (2008) 0.89
Visceral leishmaniasis in India: promises and pitfalls of a PCR-based blood test. Trans R Soc Trop Med Hyg (2002) 0.87
MicroRNAs in the brain: it's regulatory role in neuroinflammation. Mol Neurobiol (2013) 0.87
Predicting future risk of depressive episode in adolescents: the Chicago Adolescent Depression Risk Assessment (CADRA). Ann Fam Med (2008) 0.87
Pre-conditioning induces the precocious differentiation of neonatal astrocytes to enhance their neuroprotective properties. ASN Neuro (2011) 0.86
Neural stem cells in the subventricular zone are a source of astrocytes and oligodendrocytes, but not microglia. Dev Neurosci (2003) 0.86
Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm Res (2012) 0.86
Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection. PLoS One (2012) 0.85
Microglial response to viral challenges: every silver lining comes with a cloud. Front Biosci (Landmark Ed) (2011) 0.85
Epigenetic regulation of self-renewal and fate determination in neural stem cells. J Neurosci Res (2011) 0.85
Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts' innate immune response. Cell Immunol (2013) 0.85
A study of cytokines in tuberculous meningitis: clinical and MRI correlation. Neurosci Lett (2010) 0.84
Ciliary neurotrophic factor and interleukin-6 differentially activate microglia. J Neurosci Res (2008) 0.84
Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation. Neurosci Lett (2010) 0.83
Protective effects of interleukin-6 in lipopolysaccharide (LPS)-induced experimental endotoxemia are linked to alteration in hepatic anti-oxidant enzymes and endogenous cytokines. Immunobiology (2009) 0.83
Differential expression of protein tyrosine kinase genes during microglial activation. Glia (2002) 0.83
Chandipura virus induces neuronal death through Fas-mediated extrinsic apoptotic pathway. J Virol (2013) 0.83
Astrocytic ceruloplasmin expression, which is induced by IL-1beta and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor. Glia (2003) 0.83
Health utilities for children and adults with type 1 diabetes. Med Care (2011) 0.83
Bispidine-amino acid conjugates act as a novel scaffold for the design of antivirals that block Japanese encephalitis virus replication. PLoS Negl Trop Dis (2013) 0.82
Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice. J Inflamm (Lond) (2014) 0.82
Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation. J Neuroinflammation (2012) 0.82